Moreover, a single‐blind clinical study indicate that vitamin E supplementation at a dose of 400 IU (268 mg) may reduce total IgE levels in patients with AD, further supporting its therapeutic potential in mitigating allergic inflammation [19]. This evidence concerns the gene IGHE and Alzheimer disease.